Skip to main content

Table 2 Adverse Reactions Categorized by Severity and Agent

From: 2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry

Agent

N° of Examinations

N° of Adverse Reactions

Mild

Moderate

Severe

Total

Gadopentetat (e.g. Magnevist)

12810

18 (0.14)

0

2 (0.02)

20 (0.16)

Gadoteracid (e.g. Dotarem)

4235

5 (0.12)

0

0

5 (0.12)

Gadobenat (e.g. Multihance)

706

3 (0.42)

0

0

3 (0.42)

Gadobutrol (e.g. Gadovist)

9378

9 (0.1)

0

0

9 (0.10)

Gadoteridol (e.g. Prohance)

1045

2 (0.19)

0

0

2 (0.19)

Gadodiamide (e.g. Omniscan)

6116

3 (0.05)

0

0

3 (0.05)

Other

3498

3 (0.09)

0

0

3 (0.09)

Total

37788

43 (0.11)

0

2 (0.01)

45 (0.12)

  1. Note - Values in parentheses are percentages